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Abstract
Objective: to provide a preliminary estimate of the effectiveness of the prevention of delirium (POD) system of care in
reducing incident delirium in acute hospital wards and gather data for a future definitive randomised controlled trial.
Design: cluster randomised and controlled feasibility trial.
Setting: sixteen acute care of older people and orthopaedic trauma wards in eight hospitals in England and Wales.
Participants: patients 65 years and over admitted to participating wards during the trial period.
Interventions: participating wards were randomly assigned to either the POD programme or usual care, determined by
existing local policies and practices. e POD programme is a manualised multicomponent delirium prevention intervention
that targets 10 risk factors for delirium. e intervention wards underwent a 6-month implementation period before trial
recruitment commenced. Main outcome measure incidence of new-onset deliriummeasured using the Confusion Assessment
Method (CAM) measured daily for up to 10 days post consent.
Results: out of 4449, 3274 patients admitted to the wards were eligible. In total, 714 patients consented (713 registered) to
the trial, thirty-three participants (4.6%) withdrew. Adherence to the intervention was classified as at least medium for seven
wards. Rates of new-onset delirium were lower than expected and did not differ between groups (24 (7.0%) of participants
in the intervention group versus 33 (8.9%) in the control group; odds ratio (95% confidence interval) 0.68 (0.37–1.26);
P = 0.2225).
Conclusions: based on these findings, a definitive trial is achievable and would need to recruit 5220 patients in 26 two-ward
hospital clusters.
Trial registration: ISRCTN01187372. Registered 13 March 2014.
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Key points
• Multicomponent delirium prevention interventions can reduce incident delirium in hospitalised patients by about one
third.
• e National Health Service in England does not have a delirium prevention system of care suitable for national
implementation.
• We feasibility tested a multicomponent delirium prevention intervention capable of widespread NHS implementation.
• e intervention was tested in a multicentre, pragmatic, cluster randomised, controlled feasibility study.
• Based on the findings, a definitive trial is achievable and would need to recruit 5220 patients in 26 two-ward hospital
clusters.
Introduction
Delirium is a common and serious condition in older
people associated with distress for individuals, families and
health care staff [1], increased mortality, protracted lengths
of hospital stay, lasting functional and cognitive decline
and increased requirement for long-term care placement
[2]. Prevention of delirium (POD) is therefore highly
desirable and multicomponent prevention interventions
that aim to attenuate modifiable delirium risk factors have
consistently been shown to reduce incident delirium in
hospitalised patients by about one third in various inpatient
specialties [3–5]. As a consequence of this evidence base,
several national guidance documents have recommended
that multicomponent delirium prevention interventions
should be incorporated into routine care [6–8]. A major
issue faced by theNational Health Service (NHS) in England
and Wales, and acknowledged by the National Institute for
Health and Care Excellence (NICE) [6], is the lack of a
delirium prevention system of care suitable for widespread
national implementation. To address this, we developed
[9] and preliminary tested [10] the POD programme
based on the Hospital Elder Life Program [11] and NICE
guideline [6].
Previous multicomponent delirium prevention trials have
been predominantly single centre, explanatory (‘proof of
concept’) studies. Ideally, future studies should be designed
and conducted as multicentre, pragmatic evaluations in
which the intervention is implemented and delivered by
existing ward teams rather than by research staff [12]. e
design of such trials requires critical information, such
as prior estimates of effectiveness and recruitment rates.
We therefore report here a multicentre, pragmatic, cluster
randomised, controlled feasibility trial to obtain preliminary
estimates of effectiveness of the modified version of the POD
programme (Version 2), to assess recruitment and follow-up
rates and to assess adherence to the intervention (reported
in a companion paper [13]).
Methods
Trial design
A pragmatic, multicentre, cluster randomised, controlled
feasibility trial to investigate the feasibility of a future
definitive trial to assess effectiveness of the POD system
of care compared to usual care. Trial methods have been
fully described previously [14] and are summarised here.
e study was approved by the UK National Research
Ethics Service (reference 13/YH/0400). Data collection was
undertaken by locally based research assistants (RAs) who
were trained in study procedures and outcome measures.
Study setting
We aimed to recruit 16 care of older people and orthopaedic
trauma wards in 8 NHS hospitals in England and Wales.
Wards needed to be ‘site-ready’ defined as having the fol-
lowing: (i) involvement from a senior nurse, ward manager
and voluntary services manager (if volunteers were to be
part of the programme); (ii) a named person responsible
for implementation of the POD programme (e.g. the senior
nurse); (iii) dedicated time (equivalent to 1 day a week) of
an experienced senior nurse to lead the implementation; and
(iv) adequate ward staffing levels (Supplementary A1).Wards
that had participated in previous studies within the research
programme or were intending to implement delirium pre-
vention initiatives during the duration of the study were not
eligible.
Participants
Patients were eligible for trial recruitment if they were aged
over 65 years and admitted to the study wards during the
study period. Patients were excluded if delirium was present
on admission to the ward, discharge was planned within 48 h
of admission, delirium assessment had not been performed
by an RA within 24 h of admission (older people’s care
patients) or preoperatively (orthopaedic trauma patients),
consent had not been obtained with 48 h of admission to
the ward, end of life care was being provided or the patient
was under the care of another ward.
Study intervention
e POD system of care [9] targets the 10 modifiable
delirium risk factors highlighted by NICE [6]. It is directed
at changing staff practices and engaging volunteers (where
available) to facilitate enhancement of care in defined areas. It
incorporates systems and mechanisms aimed at introducing,
implementing, embedding and sustaining the intervention
in routine care and as such has common content and mech-
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anisms but with flexible implementation [9]. Further details
are provided in Supplementary A1.
Screening assessment (prior to recruitment)
Patients admitted to participating wards were screened by
RAs using the trial eligibility criteria. Screening included the
following: the collection of demographic information (age,
sex and ethnicity), date and time of admission to hospital
and ward, assessment of capacity, assessment for prevalent
delirium using the Confusion Assessment Method (CAM)
[15] the scoring of which was informed by the Months of
the Year Backwards (MOTYB) test for inattention [16] and
the abbreviated mental test (AMT) for cognitive impairment
[17].
Baseline assessment
Baseline demographic information included the following:
living arrangements (alone, another person, nursing home,
residential care home and other); reason for admission (hip
fracture, other orthopaedic condition or medical condi-
tion); co-morbidities (Charlson index) [18]; presence of spe-
cific delirium risk factors (hearing/visual impairment, cog-
nitive impairment and/or dementia); specific medications
most closely associated with delirium (benzodiazepines, opi-
ates and antihistamines) [19]; illness severity (early warning
score) [20]; pre-admission independence [21].
Patient outcomes
Most new-onset delirium occurs in the first few days after
admission [22]. We therefore assessed for differences in new-
onset delirium within 10 days of providing consent between
patients in the intervention group (POD programme) and
control group (usual care) as this is the expected primary
outcome for a definitive trial. Delirium was assessed using
the four-item CAM [15]. A CAM training and monitoring
process was developed that followed recommended practices
[23].
We also investigated between-group differences in the
number, severity [24] and duration of delirium episodes;
length of stay in hospital; mortality; and discharge destina-
tion. Physical and social independence were measured by the
RAs at baseline and at 3 months (postal questionnaire) using
the Nottingham extended activities of daily living scale [21].
Anxiety and depression were measured using the clinical
anxiety scale [25] and the geriatric depression scale short
form [26], respectively, at 30 days at an RA visit.
Blinding
eRAs administering and collecting the outcome measures
had no role in the intervention development or delivery.
As RAs were visiting the wards daily to conduct delirium
assessments it was unrealistic for them to remain blind to
treatment allocation. Post-discharge outcomes were under-
taken blind to allocation.
Sample size
As this was a feasibility study, a formal power calculation was
not considered appropriate. Based on assumptions of (i) a
6 month recruitment period, (ii) an average length of stay
of 14 days, (iii) 25-bed wards, (iv) 50% of patients fulfilling
the entry criteria, (v) 30% of patients providing consent/con-
sultee declaration [27,28], we expected 720 patients could
be recruited in 6 months, with approximately 45 patients
recruited per ward, across 16 wards.
Randomisation
e POD programme is a ward-based intervention that aims
to affect staff skills, knowledge and clinical practice. Cluster
randomisation was therefore chosen to reduce between-
group contamination. Randomisation was stratified by
ward type/speciality (older people’s care versus orthopaedic
trauma) in a two-stage process. Hospitals were first ran-
domised to either hospital or ward level delivery, following
this, the wards in those hospitals randomised to ward-level
implementation were then randomised (Supplementary A2).
Wards randomised to deliver the intervention were given
6 months to implement the POD programme followed
by 6 months of intervention delivery during which patient
recruitment took place.
Statistical methods
All analyses and data summaries were conducted on the
intention-to-treat population, defined as all participants reg-
istered, regardless of non-compliance with the protocol or
withdrawal from the study. For this feasibility study, the anal-
ysis focused on descriptive statistics and confidence interval
(CI) estimation rather than on formal hypothesis testing.
For estimation of effectiveness, we calculated the inci-
dence of new-onset delirium within 10 days of providing
consent by study arm and overall, together with correspond-
ing 95% CIs. We used multilevel logistic regression that
adjusted for age, gender, risk factors for delirium (medica-
tions associated with delirium, hearing impairment, visual
impairment and early warning score category), cognitive
impairment and/or dementia, Charlson comorbidity index,
ward type. e intracluster correlation coefficient was calcu-
lated using the incidence of new-onset delirium expressed as
a proportion of the recruited study population.
Results
Recruitment rate and follow-up
Twenty hospitals expressed interest of which 12 returned site
survey forms and eight hospitals were recruited. Of the four
hospitals not recruited, twowithdrew, one did not respond to
the request for a site visit and one was unable to supply timely
regulatory approvals. Of the 16 recruited wards, nine were
older people’s care medicine (five in the intervention group
and four in the control group) and seven were orthopaedic
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Figure 1. CONSORT diagram. Asterisk shows other reasons for ineligibility were listed as: previously screened (7); patient died
(1); and non-UK resident (1). Dagger shows other reasons delirium assessment was not performed were listed as: staffing issues (2);
unable to complete CAM (2); patient on another ward (1); previously screened (1); patient on holiday (1); and patient lives 1 h drive
away (1). Double dagger shows withdrawals here are from researcher questionnaires. Section sign shows withdrawals here are from
postal questionnaires, one patient in the POD arm withdrew from researcher visits at 30 days but not from postal questionnaires at
3 months.
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Table 1. Characteristics of participants. Values are numbers (percentages) unless stated otherwise
Characteristics Intervention group (n = 343) Control group (n = 370)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ward type
Older people’s care 212 (61.8) 180 (48.6)
Orthopaedic trauma 131 (38.2) 190 (51.4)
Participant characteristics
Mean (SD) age (years) 82.5 (7.9) 83.0 (7.8)
Women 231 (67.3) 256 (69.2)
White 326 (95.0) 328 (88.6)
Living at home 311 (90.7) 339 (91.6)
Reason for hospital admission
Hip fracture 71 (20.7) 99 (26.8)
Other orthopaedic condition 60 (17.5) 102 (27.6)
Medical condition 211 (61.5) 169 (45.7)
Missing 1 (0.3) 0 (0.0)
Risk factors for delirium
Cognitive impairment and/or dementia 83 (24.2) 67 (18.1)
Severely illa 66 (19.2) 47 (12.7)
Hearing impairment 120 (35.0) 112 (30.3)
Hearing aid use 78 (65.0) 72 (64.3)
Visual impairment 298 (86.9) 336 (90.8)
Benzodiazepines prescribed 17 (5.0) 15 (4.1)
Opiates prescribed 145 (42.3) 172 (46.5)
H1 antihistamines prescribed 43 (12.5) 33 (8.9)
Comorbidities 236 (68.8) 244 (65.9)
Mean (SD) Charlson comorbidity index score 1.7 (2.0) 1.7 (1.9)
aMedium or high national early warning score category within 48 h of admission.
trauma (three in the intervention group and four in the
control group).
In 16 wards, 4449 patients were admitted and screened
for eligibility of whom 3274 (73.6%) were considered ini-
tially eligible (Figure 1). e principal reasons for study
exclusion were prevalent delirium (12.1%) and expected
duration of stay less than 48 h (7.9%). Delirium assessment
was performed by the RAs on 1537 (46.9%) of initially
eligible patients; the main reasons for non-assessment of
delirium included the research staff missing the patient
(21.1% of initially eligible) and ward staff advised not to
approach (11.4%). A further 113 of these patients had delir-
ium and were excluded. Consent to participate in the study
was obtained for 714 (50.4% of 1418 patients) with 343 and
370 (10.5% and 11.3% of those eligible) participants reg-
istered to the intervention and control groups, respectively
(one person was discharged before registration). Only 33
(4.6%) of participants withdrew from the study (19 (57.6%)
withdrawals occurred within 10 days of providing consent).
Baseline characteristics of wards and randomised
participants
ere were more patients admitted with a medical condition
in the intervention group compared to the control group
(211 (61.5%) versus 169 (45.7%), respectively) due to an
imbalance in ward type randomisation (Table 1). Participant
demographic characteristics were similar between the arms.
e intervention group hadmore participants with cognitive
impairment/dementia than the control group (83 (24.2%)
versus 67 (18.1%), respectively), and more participants who
were severely ill (66 (19.2%) versus 47 (12.7%), respectively)
as measured using the early warning score [20].
Implementation of and adherence to the
intervention
All wards allocated to the intervention implemented the
POD programme (Supplementary A3). Overall adherence
to the POD programme measured in four domains (ward set
up, content and frequency of delivery, intervention coverage
and duration of delivery) was classified as high in two wards,
medium in five wards and low in the remaining ward (low
in all domains except ward set up) (Supplementary A4).
Study outcomes
Delirium
Taking into account length of patient stay, deaths and
withdrawals and discharges, there were a possible 5645 in-
hospital CAM assessments of which 5065 (89.7%) were
conducted by the RAs. e CAM scoring was informed
by the AMT and the MOTYB test with completion rates
of 100% and 99.5%, respectively. Out of 713, 57 (8.0%)
participants developed new-onset delirium within 10 days
of providing consent: 24 (7.0%) of 343 participants in
the intervention group and 33 (8.9%) of 370 participants
in the control group (Table 2). New-onset delirium was
higher in the orthopaedic trauma wards compared to the
older people’s care wards (10.0% versus 6.4%, respectively)
(Supplementary A5). Delirium incidence in sites ranged
between 4.6 and 12.9% (Supplementary A5). Delirium
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Table 2. Outcomes. Values are numbers (percentages) unless stated otherwise
Outcome Intervention group (n = 343) Control group (n = 370)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
New-onset delirium within 10 days of providing consent 24 (7.0)a 33 (8.9)a
No. of CAM assessments indicating delirium within 10 days of providing consent 48/2382 (2.0) 57/2683 (2.1)
Mean (SD) severity of delirium episodesb 3.9 (1.0) 3.8 (1.0)
Mean (SD) duration of delirium episodes (days) 2.3 (2.0) 2.2 (1.9)
Mean (SD) time to first delirium episode (days) 4.0 (1.9) 4.2 (2.3)
Delirium at 30 days 6 (1.7) 3 (0.8)
Mean (SD) severity of delirium at 30 daysb 3.7 (0.8) 3.3 (0.6)
Fallsc
Number of participants 12 (3.5) 17 (4.6)
Number of falls 19 20
Mean (SD) number of falls per participant 1.6 (1.0) 1.2 (0.4)
Deaths
Within 10 days of providing consent 17 (5.0) 11 (3.0)
Overall 61 (17.8) 53 (14.3)
Mean (SD) time to death (days) 33.1 (26.9) 36.8 (29.2)
Mean (SD) length of hospital stay (days) 9.7 (7.1) 9.8 (6.9)
Within-hospital ward moves 58 (16.9) 77 (20.8)
Discharge (n = 248) (n = 288)
New care home placement 47 (19.0) 71 (24.7)
Overnight stays in hospitald (n = 144) (n = 193)
Mean (SD) 18.1 (22.3) 15.9 (17.3)
Nottingham extended activities of daily living scale (Total score)
Baseline (n = 334) (n = 364)
Mean (SD) 36.7 (18.4) 39.7 (19.0)
ree months (n = 173) (n = 220)
Mean (SD) 29.5 (20.3) 33.1 (20.9)
Geriatric depression score at 30 days (n = 199) (n = 278)
Mean (SD) total score 4.7 (3.5) 4.2 (3.3)
Clinical anxiety scale at 30 days (n = 180) (n = 276)
Mean (SD) total score 16.8 (15.4) 16.9 (14.8)
aP = 0.2225, odds ratio 0.68 (95% CI 0.37, 1.26). bScored with the CAM-S, score range 0–7. cBetween consent and hospital discharge, death or withdrawal
(whichever was sooner). dBetween index ward admission and 3 months.
incidence rates in those sites randomised at the hospital level
were similar between the arms (2.5% intervention versus
2.3% control); for those randomised at a ward level rates
were 1.6% intervention versus 1.9% control.
Multilevel logistic regression analysis (adjusting for
baseline covariates: age, sex, prescription of benzodiazepines,
opiates and antihistamines [19], hearing impairment, visual
impairment, ward type, early warning score, cognitive
impairment and Charlson comorbidity index) was used to
explore the differences in incidence of delirium between
randomised arms. Patients in the POD programme arm had
lower odds of developing delirium but this result was not
statistically significant (odds ratio 0.68; 95% CI 0.37 to
1.26; P-value 0.2225) (Supplementary A6). e intracluster
correlation coefficient was calculated as 0.0002.
Other outcomes
Falls, mortality, length of hospital stay, social and physical
activities and depression and anxiety were similar between
the intervention and control groups (Table 2).
Discussion
e multicomponent (non-pharmacological) delirium
literature is dominated by small to medium sized, single
site, predominantly non-randomised evaluation studies [3–
6] that are prone to several biases [29]. is is the first suc-
cessfully completed multicentre multicomponent delirium
prevention randomised controlled trial, albeit a preliminary
feasibility study. We were able to recruit a vulnerable group
of patients and achieved high outcome assessment and
follow-up rates. e other similar multicentre trial involved
only two hospitals but was unable to recruit sufficient
patients and had large amounts ofmissing data [30].Wewere
able to consent 714 patients from eight hospitals/16 wards
over 6months against our target of 720.Our target was based
on several assumptions. We assumed that approximately
50% of patients would be at risk of developing delirium.
In fact nearly three quarters of the patients on these older
people’s care and orthopaedic trauma wards were at risk
based on the criteria published by NICE [6]. We further
assumed that 30% of patients eligible for the study would
be recruited; in this study it was 21.8%. In practice, we
found that the major barrier to recruitment was inability
to conduct a baseline CAM assessment to exclude prevalent
delirium, largely because some patients were judged too
sick by the ward staff or because some patients were
not identified for assessment within 24 h of admission
(older people’s care patients) or preoperatively (orthopaedic
patients). e baseline CAM assessment was not achieved
for 1737/3274 (53.1%) of the apparently eligible patients.
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e consent rate for eligible patients for whom delirium
was not present was higher than anticipated at 50.4%. e
overall recruitment rate was 16% of screened patients, which
was consistent with our prior assumption of 15% but the
recruitment rate might be readily enhanced if there was
a greater focus on RA engagement with patients during
the first 24 h of admission. Losses to follow-up were low:
only 4.6% of patients withdrew from study follow-up and
16.0% of patients died within the study. We did not detect
high levels of contamination in those sites that included
both intervention and control wards suggesting that it is
possible to randomise wards within a hospital to receive
different interventions. ese are important findings which
can be used to plan future similar studies involving this
mixed population of older people’s care and orthogeriatric
patients.
e population recruited to this trial were older people
(mean age 82.7 years, SD = 7.8); 21.0% had dementia/cog-
nitive impairment; 67.3% had co-morbidities; 23.8% had
been admitted with a hip fracture and 44.5% were taking an
opiate. It might be reasonably expected, therefore, that this
patient population would be at high risk for delirium [6].
Indeed, at least 14.6% of the 4449 patients screened (not all
patients assessed due to time constraints) had prevalent delir-
ium (delirium on admission). However, the rate of incident
(new) delirium was lower than anticipated: 8% compared
to 17.7% for a combined medical and orthogeriatric pop-
ulation reported in the randomised studies included in the
Cochrane Review (N = 39 studies; n = 16,082 patients) [5].
e explanation for the low delirium incidence in the trial
population is unclear. It is possible that greater awareness of
delirium has resulted in improvements in NHS ward care
and a subsequent reduction in delirium incidence. However,
successive rounds of the National Audit of Dementia Care in
General Hospitals have demonstrated continuing dementia
and delirium care deficiencies in NHS hospitals in England
and Wales [31]. Despite this, it is possible that staff and
wards with a pre-existing interest in delirium prevention
were more likely to participate with our study resulting in
a study site selection bias and lower than anticipated rates
of delirium.
e low rate of delirium was not related to missing delir-
ium assessments as the RAs completed 89.7% of expected
CAM assessments during the 10 days after patient randomi-
sation. e delirium incidence rates showed some variation
between sites (4.6–12.9%). is suggests some variation
in either individual RA delirium assessment performance,
or differences in local care environments that influenced
the development of delirium. However, the between-site
variation in delirium incidence was well within, and in no
case exceeded, the pooled estimate value reported in the
Cochrane review.
e adjusted odds ratio of 0.68 for delirium incidence for
the patients randomised to the POD programme compared
to usual care is entirely consistent with previous studies [3–
6]. However, the 95% CIs were wide: 0.37–1.26. is find-
ing is not surprising as the study was not powered to provide
a definitive evaluation of the POD programme. Successful
implementation and delivery are critical formulticomponent
interventions. Intervention adherence was classified as high
in two wards, medium in five wards and low in one ward.
Obviously, greater levels of intervention adherence might
have influenced the effectiveness estimate of POD.However,
the trial was purposefully designed as a pragmatic study,
that is, ward changes were led by existing ward staff rather
than research staff. e findings are therefore likely to be
generalisable to delirium prevention in routine care and form
a more reliable basis to plan future studies. Based on the
delirium incidence rates we observed, a definitive cluster
randomised study would need to be far larger than any pre-
vious multicomponent delirium prevention study. Assuming
a significance level of 5%, a study power of 90%, a delirium
incidence reduction of 30% (consistent with previous studies
and our own), incorporating the observed control group
incidence rate of 8.9%, allowing for 15% loss to follow-up,
and using the unadjusted intracluster correlation coefficient
value obtained here (0.0002), the trial would need to recruit
5220 patients in 26 two-ward hospital clusters (200 patients
per cluster). is clearly represents a substantial trial but is
the only way to obtain robust evidence of effectiveness to
support or refute a national roll-out of the POD programme,
or a similar intervention. e findings from our feasibility
trial suggest a larger study would be achievable and pro-
vides valuable underpinning methodological information to
design the study.
Supplementary data: Supplementary data mentioned in
the text are available to subscribers in Age and Ageing online.
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